Abstract
Small heat shock proteins(sHSPs), with a small molecular mass of 12-43 kDa, are molecular chaperones that protect cells against stress by assisting them in the correct folding of denatured proteins and thus prevent aggregation of misfolded proteins. During the past several years, there has been an increasing interest in the relationship between sHSPs and neuropathy. sHSPs have emerged as a particularly potent neuroprotectant in diverse neurological disorders. Therefor, in this review, we will focus on the expression of sHSPs in different neurological disorders, and discuss the recent findings of the biological implications of sHSPs in physiological and pathological processes in these diseases. Novel therapeutic strategies aiming at restoring sHSPs in neuropathy will also be presented.
Keywords: Cerebral ischemia, demyelination diseases, neurodegenerative disorders, neuropathy, seizures, small heat shock proteins(sHSPs)
Current Neurovascular Research
Title: Small Heat Shock Proteins: Recent Advances in Neuropathy
Volume: 7 Issue: 2
Author(s): Liuwang Zeng, Zhiping Hu, Wei Lu, Xiangqi Tang, Jie Zhang, Ting Li and Binbin Yang
Affiliation:
Keywords: Cerebral ischemia, demyelination diseases, neurodegenerative disorders, neuropathy, seizures, small heat shock proteins(sHSPs)
Abstract: Small heat shock proteins(sHSPs), with a small molecular mass of 12-43 kDa, are molecular chaperones that protect cells against stress by assisting them in the correct folding of denatured proteins and thus prevent aggregation of misfolded proteins. During the past several years, there has been an increasing interest in the relationship between sHSPs and neuropathy. sHSPs have emerged as a particularly potent neuroprotectant in diverse neurological disorders. Therefor, in this review, we will focus on the expression of sHSPs in different neurological disorders, and discuss the recent findings of the biological implications of sHSPs in physiological and pathological processes in these diseases. Novel therapeutic strategies aiming at restoring sHSPs in neuropathy will also be presented.
Export Options
About this article
Cite this article as:
Zeng Liuwang, Hu Zhiping, Lu Wei, Tang Xiangqi, Zhang Jie, Li Ting and Yang Binbin, Small Heat Shock Proteins: Recent Advances in Neuropathy, Current Neurovascular Research 2010; 7 (2) . https://dx.doi.org/10.2174/156720210791184934
DOI https://dx.doi.org/10.2174/156720210791184934 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Designed Multiple Ligands: Basic Research vs Clinical Outcomes
Current Medicinal Chemistry Cannabinoids and Neuroprotection in Motor-Related Disorders
CNS & Neurological Disorders - Drug Targets Ginkgo Biloba Extract (EGb 761) and CNS Functions Basic Studies and Clinical Applications
Current Drug Targets Cholinesterase Inhibitory Activities of N-Phenylthiazol-2-Amine Derivatives and their Molecular Docking Studies
Medicinal Chemistry Targeting Conserved Pathways: Mitochondrial Dysfunction and Beyond
Current Neurovascular Research Current Status and Perspectives in Ceramide-Targeting Molecular Medicine
Current Pharmaceutical Design The Impact of Docosahexaenoic Acid on Alzheimer’s Disease: Is There a Role of the Blood-Brain Barrier?
Current Clinical Pharmacology Therapeutic Approach to Multiple Sclerosis by Novel Oral Drugs
Recent Patents on Inflammation & Allergy Drug Discovery Flavones from Root of Scutellaria Baicalensis Georgi: Drugs of the Future in Neurodegeneration?
CNS & Neurological Disorders - Drug Targets Multi-Target-Directed Ligands Affecting Serotonergic Neurotransmission for Alzheimer’s Disease Therapy: Advances in Chemical and Biological Research
Current Medicinal Chemistry Inhibitory Mechanism of An Anticancer Drug, Bexarotene Against Amyloid β Peptide Aggregation: Repurposing Via Neuroinformatics Approach
Current Pharmaceutical Design Metallothioneins and Synthetic Metal Chelators as Potential Therapeutic Agents for Removal of Aberrant Metal Ions from Metal-Aβ Species
Mini-Reviews in Medicinal Chemistry Neurovascular Matrix Metalloproteinases and the Blood-Brain Barrier
Current Pharmaceutical Design Advantages of Vasoactive Intestinal Peptide for the Future Treatment of Parkinson’s Disease
Current Pharmaceutical Design Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging
Current Molecular Pharmacology Rhein-Huprine Derivatives Reduce Cognitive Impairment, Synaptic Failure and Amyloid Pathology in AβPPswe/PS-1 Mice of Different Ages
Current Alzheimer Research Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Forms of Iron Binding in the Cells and the Chemical Features of Chelation Therapy
Mini-Reviews in Medicinal Chemistry Discovery and Optimization of Pyrazoline Derivatives As Promising Monoamine Oxidase Inhibitors
Current Topics in Medicinal Chemistry Monoamine Oxidases: The Biochemistry of the Proteins As Targets in Medicinal Chemistry and Drug Discovery
Current Topics in Medicinal Chemistry